Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug. Insys gave $500,000…
Source: Morningcall
DEA OKs synthetic marijuana for pharma company that spent $500,000 to keep pot illegal
More from NewsMore posts in News »
- Donald Trump wins Missouri caucuses. Michigan and Idaho Republicans will also weigh in on 2024 race
- Police charge man in murder of Amish woman
- Retail Watch: Would you get a haircut at the gym?
- Oregon resident has the plague. Here’s what to know.
- Winter weather advisory issued for Lehigh Valley: Snow expected Friday into Saturday
You must be logged in to post a comment.